Gentian Diagnostics Management
Management criteria checks 2/4
Gentian Diagnostics' CEO is Njaal Kind, appointed in Apr 2024, has a tenure of less than a year. total yearly compensation is NOK3.04M, comprised of 71.1% salary and 28.9% bonuses, including company stock and options. directly owns 0.17% of the company’s shares, worth €92.41K. The average tenure of the management team and the board of directors is 1.8 years and 2 years respectively.
Key information
Njaal Kind
Chief executive officer
NOK 3.0m
Total compensation
| CEO salary percentage | 71.1% |
| CEO tenure | less than a year |
| CEO ownership | 0.2% |
| Management average tenure | 1.8yrs |
| Board average tenure | 2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | NOK 2m |
| Jun 30 2024 | n/a | n/a | -NOK 2m |
| Mar 31 2024 | n/a | n/a | -NOK 6m |
| Dec 31 2023 | NOK 3m | NOK 2m | -NOK 11m |
| Sep 30 2023 | n/a | n/a | -NOK 5m |
| Jun 30 2023 | n/a | n/a | -NOK 14m |
| Mar 31 2023 | n/a | n/a | -NOK 18m |
| Dec 31 2022 | NOK 3m | NOK 2m | -NOK 24m |
| Sep 30 2022 | n/a | n/a | -NOK 29m |
| Jun 30 2022 | n/a | n/a | -NOK 26m |
| Mar 31 2022 | n/a | n/a | -NOK 26m |
| Dec 31 2021 | NOK 3m | NOK 2m | -NOK 25m |
| Sep 30 2021 | n/a | n/a | -NOK 19m |
| Jun 30 2021 | n/a | n/a | -NOK 19m |
| Mar 31 2021 | n/a | n/a | -NOK 17m |
| Dec 31 2020 | NOK 2m | NOK 2m | -NOK 17m |
| Sep 30 2020 | n/a | n/a | -NOK 21m |
| Jun 30 2020 | n/a | n/a | -NOK 19m |
| Mar 31 2020 | n/a | n/a | -NOK 38m |
| Dec 31 2019 | NOK 2m | NOK 2m | -NOK 40m |
Compensation vs Market: Njaal's total compensation ($USD274.54K) is below average for companies of similar size in the German market ($USD474.67K).
Compensation vs Earnings: Njaal's compensation has been consistent with company performance over the past year.
CEO
Njaal Kind
less than a year
Tenure
NOK 3,041,000
Compensation
Mr. Njaal Kind serves as Acting Chief Executive Officer since April 29, 2024 and Chief Financial Officer at Gentian Diagnostics AS and serves as its Chief Operating Officer. Mr. Kind has experience and ext...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairperson | less than a year | NOK 4.37m | 0.042% € 23.1k | |
| Acting CEO | less than a year | NOK 3.04m | 0.17% € 92.4k | |
| Chief Scientific Officer | 1.8yrs | NOK 1.90m | 0.013% € 7.1k | |
| Chief Commercial Officer | no data | NOK 2.83m | no data | |
| Head of Innovation & Research | 2.8yrs | no data | no data | |
| Head of Product Development | 2.8yrs | no data | no data |
1.8yrs
Average Tenure
Experienced Management: 6FK's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairperson | less than a year | NOK 4.37m | 0.042% € 23.1k | |
| Independent Director | 2.5yrs | no data | no data | |
| Independent Director | no data | no data | 0.015% € 8.2k | |
| Independent Director | no data | no data | 0.11% € 60.1k | |
| Non-Executive Independent Director | 1.5yrs | no data | no data | |
| Non-Executive Director | 2.5yrs | no data | 0.18% € 99.6k |
2.0yrs
Average Tenure
59yo
Average Age
Experienced Board: 6FK's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.